Diffuse large B-cell lymphoma on the back of a patient with AIDS:: Successful treatment by the CD20 monoclonal antibody rituximab

被引：1
|
作者：
Voigtländer, C
Harrer, T
Schneider, L
Schulze-Koops, H
Niedobitek, G
Lüftl, M
机构：
[1] Univ Hosp Erlangen, Dept Dermatol, D-91052 Erlangen, Germany
[2] Univ Hosp Erlangen, Dept Med 3, Erlangen, Germany
[3] Univ Erlangen Nurnberg, Inst Pathol, Erlangen, Germany
来源：
INTERNATIONAL JOURNAL OF DERMATOLOGY | 2005年 / 44卷 / 11期
关键词：
D O I：
10.1111/j.1365-4632.2005.02649.x
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：976 / 978
页数：4
相关论文
共 50 条
  • [41] Lack of Utility of CD20 Immunohistochemistry in Staging Bone Marrow Biopsies for Diffuse Large B-cell Lymphoma
    Baiyee, Daniel
    Warnke, Roger
    Natkunam, Yasodha
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2009, 17 (02) : 93 - 95
  • [42] Anti-CD20 monoclonal antibody as a new treatment modality for B-cell lymphoma
    Hotta, T
    ACTA HISTOCHEMICA ET CYTOCHEMICA, 2002, 35 (04) : 275 - 279
  • [43] Role of Rituximab and Rituximab Biosimilars in Diffuse Large B-Cell Lymphoma
    Coleman, Morton
    Lammers, Philip E.
    Ciceri, Fabio
    Jacobs, Ira A.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2016, 16 (04): : 175 - 181
  • [44] Successful treatment and re-treatment of resistant B-cell chronic lymphocytic leukemia with the monoclonal anti-CD 20 antibody rituximab
    Herold, M
    Schulze, A
    Härtwig, K
    Anger, G
    ANNALS OF HEMATOLOGY, 2000, 79 (06) : 332 - 335
  • [45] Successful treatment and re-treatment of resistant B-cell chronic lymphocytic leukemia with the monoclonal anti-CD 20 antibody rituximab
    M. Herold
    A. Schulze
    K. Härtwig
    G. Anger
    Annals of Hematology, 2000, 79 : 332 - 335
  • [46] Rituxan™:: Anti CD20 monoclonal antibody for the treatment of lymphoma.
    Grillo-López, AJ
    White, CA
    Dallaire, BK
    Varns, C
    Shen, D
    McClure, A
    EXPERIMENTAL HEMATOLOGY, 1998, 26 (08) : 746 - 746
  • [47] Partial restoration of CD20 protein expression and rituximab sensitivity after treatment with azacitidine in CD20-negative transformed diffuse large B cell lymphoma after using rituximab
    Junji Hiraga
    Akihiro Tomita
    Naruko Suzuki
    Yusuke Takagi
    Michihiko Narita
    Yoshitoyo Kagami
    Annals of Hematology, 2018, 97 : 2253 - 2255
  • [48] Partial restoration of CD20 protein expression and rituximab sensitivity after treatment with azacitidine in CD20-negative transformed diffuse large B cell lymphoma after using rituximab
    Hiraga, Junji
    Tomita, Akihiro
    Suzuki, Naruko
    Takagi, Yusuke
    Narita, Michihiko
    Kagami, Yoshitoyo
    ANNALS OF HEMATOLOGY, 2018, 97 (11) : 2253 - 2255
  • [49] Loss of CD20 antigen expression after rituximab therapy of CD20 positive B cell lymphoma (diffuse large B cell extranodal marginal zone lymphoma combination): A case report and review of the literature
    Duman, Berna Bozkurt
    Sahin, Berksoy
    Ergin, Melek
    Guvenc, Birol
    MEDICAL ONCOLOGY, 2012, 29 (02) : 1223 - 1226
  • [50] Loss of CD20 antigen expression after rituximab therapy of CD20 positive B cell lymphoma (diffuse large B cell extranodal marginal zone lymphoma combination): A case report and review of the literature
    Berna Bozkurt Duman
    Berksoy Şahin
    Melek Ergin
    Birol Guvenc
    Medical Oncology, 2012, 29 : 1223 - 1226
12345